Sustained Release Olanzapine

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43MH068925-01A1
Agency Tracking Number: MH068925
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
AURITEC PHARMACEUTICALS, INC., 2275 E FOOTHILL BLVD, PASADENA, CA, 91107
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 THOMAS Smith
 (617) 461-6263
 TSMITH@AURITECPHARMA.COM
Business Contact
Phone: (626) 376-4070
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The long-term goal of this research is to minimize morbidity associated with psychotic disorders by developing injectable long-acting formulations of olanzapine (Zyprexa/R), currently a leading atypical antipsychotic a

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government